AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Conditions: Vulvar Adenocarcinoma; PDAC – Pancreatic Ductal Adenocarcinoma; Gastric Adenocarcinoma; GEJ Adenocarcinoma; Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Small Cell Carcinoma of Lung

Interventions: Drug: AVA6103

Sponsors: Avacta Life Sciences Ltd

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 19, 2026Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments